DNAPrint Genomics Inc. Annual stock financials by MarketWatch. View the latest DNAG financial statements, income statements and financial ratios.

DNAPrint™ genomics, Inc. has announced that it has established DNAPrint Pharmaceuticals, Inc., a wholly owned pharmaceutical subsidiary focused on personalized medicine. “Since its inception, DNAPrint ...

DNAPrint genomics Inc. said it would acquire some of the assets of Ellipsis Biotherapeutics Corp. in a stock deal valued at about $112,000. Ellipsis will sell its clinical genomics and genotyping ...

SARASOTA -- DNAPrint Genomics posted a loss of $906,292 during the first quarter as it continued efforts to milk profits out of its genetic testing products. The per-share measure of the loss is so ...

Tampa, FL (March 29, 2004) - Timothy J. Yeatman, M.D., Moffitt's Associate Center Director for Clinical Investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota-based ...

SARASOTA, Fla., June 22, 2006 (PRIMEZONE) -- DNAPrint Genomics, Inc. (OTCBB:DNAG) President and Chief Executive Officer Richard Gabriel told shareholders at the Annual Meeting today that the ...

DNAPrint genomics, Inc. uses proprietary human genome research methods to develop genomic-based services and products. The Company introduced Ancestrybydna in the consumer market and DNAWitness in the ...

DNAPrint genomics Inc. in Sarasota announced Wednesday that it has secured a commitment from La Jolla Cove Investors Inc. to invest up to $8 million in the company over approximately the next two ...

SARASOTA -- DNAPrint Genomics Inc. continued its financial losing streak in 2002, finishing the year $3.11 million in the red. That's compared with a $2.59 million loss in 2001. Since December 1998, ...

DNAPrint Genomics Inc. DNAPrint Genomics, Inc. engages in the research and development of genomics-based products and services for biomedical and forensics. The company was founded by Tony N. Frudakis ...